ALXO – alx oncology holdings inc. (US:NASDAQ)
Stock Stats
News
ALX Oncology Holdings Inc. (NASDAQ: ALXO) had its price target lowered by analysts at UBS Group AG from $4.00 to $2.20. They now have a "buy" rating on the stock.
ALX Oncology Holdings Inc. (NASDAQ: ALXO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
ALX Oncology Holdings Inc. (NASDAQ: ALXO) had its price target lowered by analysts at HC Wainwright from $25.00 to $5.00. They now have a "buy" rating on the stock.
ALX Oncology stock falls 16% amid Phase 2 data update [Seeking Alpha]
ALX Oncology Presents Positive Updated Data from ASPEN-06 Phase 2 Trial Demonstrating Evorpacept Generates Strong Response and Durable Clinical Benefit in Patients with HER2-Positive Gastric Cancer
Form SCHEDULE 13G/A ALX ONCOLOGY HOLDINGS Filed by: TANG CAPITAL PARTNERS LP
Form 4 ALX ONCOLOGY HOLDINGS For: Jan 21 Filed by: Hemrajani Rekha
Form 4 ALX ONCOLOGY HOLDINGS For: Jan 21 Filed by: Garland J. Scott
Form 4 ALX ONCOLOGY HOLDINGS For: Jan 21 Filed by: GOODMAN COREY S
Form 4 ALX ONCOLOGY HOLDINGS For: Jan 21 Filed by: Takimoto Chris H
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.